Stay updated on HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial

Sign up to get notified when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    0.2%
    Check dated 2025-01-12T18:59:02.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The website has updated to version v2.13.3, adding 'Results Submitted' while removing 'No Results Posted' from the previous version v2.13.2.
    Difference
    0.1%
    Check dated 2024-12-14T22:57:01.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.
    Difference
    2%
    Check dated 2024-12-07T16:41:52.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The website has added a 'Show less' feature, while several detailed data fields and options related to study downloads have been removed.
    Difference
    3%
    Check dated 2024-11-23T05:07:52.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    Several key health-related links have been removed, including resources from MedlinePlus, DailyMed, and various government health websites.
    Difference
    0.3%
    Check dated 2024-11-16T00:25:26.000Z thumbnail image
  9. Check
    67 days ago
    Change Detected
    Summary
    The website has added several new resources related to HIV and clinical trials, including links to MedlinePlus and DailyMed, as well as a new participant group/arm section, while the previous revision v2.12.1 has been removed.
    Difference
    3%
    Check dated 2024-11-08T18:34:58.000Z thumbnail image

Stay in the know with updates to HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.